Moreover, the levels of interferon by natural killer (NK) and T helper type 1 (Th1) CD4+, CD8+ cells limit tumor progression by activating cytotoxic immunity [15–17], and the presence of Th1 polarization markers correlate with lower tumor recurrence in CRC patients [18]. The gene discussed is CD8A; the disease is colorectal carcinoma.